{
    "Symbol": "TEVA",
    "AssetType": "Common Stock",
    "Name": "Teva Pharma Industries Ltd ADR",
    "Description": "Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel.",
    "CIK": "818686",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "5 BAZEL ST, P O B 3190, PETACH TIKVA, IL",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "19871242000",
    "EBITDA": "4565000000",
    "PERatio": "None",
    "PEGRatio": "1.843",
    "BookValue": "5.61",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.39",
    "RevenuePerShareTTM": "14.49",
    "ProfitMargin": "-0.0278",
    "OperatingMarginTTM": "0.196",
    "ReturnOnAssetsTTM": "0.0516",
    "ReturnOnEquityTTM": "-0.105",
    "RevenueTTM": "16290000000",
    "GrossProfitTTM": "6973000000",
    "DilutedEPSTTM": "-0.39",
    "QuarterlyEarningsGrowthYOY": "0.4",
    "QuarterlyRevenueGrowthYOY": "0.074",
    "AnalystTargetPrice": "20.29",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "5",
    "AnalystRatingHold": "6",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "5.59",
    "PriceToSalesRatioTTM": "0.986",
    "PriceToBookRatio": "1.986",
    "EVToRevenue": "2.05",
    "EVToEBITDA": "20.84",
    "Beta": "0.901",
    "52WeekHigh": "18.02",
    "52WeekLow": "8.05",
    "50DayMovingAverage": "16.78",
    "200DayMovingAverage": "13.1",
    "SharesOutstanding": "1132910000",
    "DividendDate": "2017-12-12",
    "ExDividendDate": "2017-11-27"
}